HIV / AIDS

The first HIV vaccine efficacy study in seven years is currently being conducted in South Africa, with researchers testing if a new vaccine regimen called HVTN 702 can provide adequate protection against HIV.

The US Department of Health and Human Services has added seven new substances to its list of carcinogens deemed harmful to human health.

Buyers clubs are still going strong in the United States and around the world as the offer a low-cost alternative for individuals with HIV and hepatitis c virus (HCV) who often find themselves struggling to pay for the expensive medications they need to treat their illness.

Scientists from the National Institute of Allergy and Infectious Diseases have discovered a broadly neutralizing antibody that is able to neutralize 98% of HIV strains.

The growing number of HIV cases in Russia suggests that global eradication of the virus may not happen by 2030.

Predicting how long it takes for an infectious disease outbreak to begin may help health officials develop an early warning system, according to the authors of a new study on lag times in epidemics.

The US Food and Drug Administration has approved Selzentry for use in pediatric patients two years of age or older, who weigh at least 10 kg.

At the Centers for Disease Control and Prevention 2016 STD Prevention Conference, lead authors of several studies discussed how researchers are taking novel approaches to sexually-transmitted infection screening.

Rapid syphilis screening tests can be useful in community-based facilities, according to the results of five studies presented in a mini-plenary on September 22 at the Centers for Disease Control and Prevention 2016 STD Prevention Conference in Atlanta, Georgia.

At the Centers for Disease Control and Prevention's 2016 STD Prevention Conference, researchers discussed three novel prevention strategies for HIV, other STIs, and unintended pregnancies.

The monoclonal antibody, ibalizumab, has proven to be both safe and effective in treating patients who are infected with multi-drug-resistant HIV-1 and have been previously treated.

At the annual meeting of the Infectious Diseases Society of America in New Orleans, Louisiana, Judith Currier, MD, from the University of California, Los Angeles, discussed the many challenges that HIV-positive individuals face as they live longer lives.

Speakers at the Infectious Diseases Society of America annual conference plenary symposium in New Orleans, Louisiana, discuss past successes, current challenges, and future efforts regarding infectious disease.

Thirty years after the 1980s AIDS crisis, researchers have proven that Gaétan Dugas, known as Patient Zero, was, in fact, not the first AIDS case.

Researchers from Sweden’s Linköping University discover the pathway that leads to deadly infections in people co-infected with HIV and TB.

During the 2016 HIV Research and Prevention (HIVR4P) meeting in Chicago, researchers conducting trials to assess the safety and efficacy of the dapivirine vaginal ring announced several key findings and insights of the ASPIRE study, known as MTN-020.

The Centers for Disease Control and Prevention reported a rise in STDs and a dent in preventive services in their 2015 Sexually Transmitted Disease Surveillance report.

Technology gives men who have sex with men (MSM) new ways to assess their health status, prevent HIV and other STDs (sexually transmitted diseases), and find care.

Older Americans who are sexually active are not being tested for HIV and are not being educated about how to prevent disease transmission, new research suggests.

New prevention and treatment models are needed worldwide and one such model is the Dean Street Express Clinic in London, England.

In a recent study, researchers investigated the treatment and prevention of HIV within trauma-informed care.

A team of researchers at the University of California has found that veterans infected with both hepatitis C and human immunodeficiency virus sought treatment more often than those infected with just one of the viruses.

Following the recent United Nations General Assembly meeting to discuss the growing global threat of antimicrobial resistance, health experts are highlighting the role vaccines can play in preventing dangerous infections.

As antibiotic-resistant bacteria continue to endanger public health, greater attention from health officials and new US federal funding aimed at fighting superbugs, signal a new urgency in this battle.